跳至主要内容
临床试验/NCT01293318
NCT01293318已完成不适用

Copeptin Pancreatitis Trial

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2011年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Association between copeptin level and severity of pancreatitis (according to Atlanta classification)

研究概览

简要总结

The purpose of this study is to investigate if there is an association between copeptin level in serum and the severity of pancreatitis and if copeptin can be used as a predictor for organ failure and pancreatic necrosis with or without superinfection.

详细描述

Acute pancreatitis may range from mild to severe disease with high mortality in case of infected pancreatic necrosis. Due to its rising incidence it remains an important healthcare problem in Europe and US. The assessment of the severity of pancreatitis is crucial for the further management and the prognosis. Several quite complex scores like Ranson or APACHE II scores has been used in the past with reasonable sensitivity for necrosis or superinfection as well as inflammation markers like c-reactive Protein.

Copeptin, the C-terminal part of antidiuretic hormone, is a relatively stable peptide in blood circulation. Several studies investigated Copeptin in the presence of Systemic Inflammatory Response Syndrome (SIRS) or sepsis, myocardial infarction, lower respiratory tract infection and cerebral stroke. Copeptin has shown to be a helpful prognostic marker in these diseases. The aim of this prospective study is to investigate whether Copeptin can be used to assess the severity of pancreatitis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of acute pancreatitis
  • written informed consent
  • inpatient treatment

排除标准

  • time interval between onset of abdominal symptoms and study inclusion >96h
  • patients unable to consent

结局指标

主要结局

Association between copeptin level and severity of pancreatitis (according to Atlanta classification)

时间窗: 48 hours

Copeptin level will be measured on admission into hospital and severity of pancreatitis will be classified according to the Atlanta criteria.

次要结局

  • Comparison of copeptin with C reactive protein and procalcitonin in terms of assessing severity of pancreatitis(48 hours)
  • Predictive accuracy of copeptin, C reactive Protein (CRP) and procalcitonin in terms of developing organ failure, necrosis and/or superinfection and mortality(Duration of hospitalisation)
  • Determine whether change in copeptin level from day 0 to 2 is associated with organ failure, necrosis and/or superinfection(Duration of hospitalisation)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验